ACAPELLA: Real-World Experience with Ocrelizumab, 6-Year Data

被引：0
|
作者：
Douglas, Elizabeth [1 ]
O'Shea, Isabella [1 ]
Greenawalt, Paige [1 ]
Bouley, Andrew [1 ]
Lathi, Ellen [1 ]
Katz, Joshua [1 ]
机构：
[1] Elliot Lewis Ctr, Wellesley, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1538/703
引用
收藏
页码：979 / 980
页数：2
相关论文
共 50 条
  • [21] Ocrelizumab use in the real-world experience: data from a hot spot area for Multiple Sclerosis
    Mellino, P.
    Lorefice, L.
    Pilotto, S.
    Frau, J.
    Pintus, M.
    Barca, S.
    Coghe, G.
    Barracciu, M.
    Cocco, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 634 - 635
  • [22] Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Fruns, Manuel
    Hornung, Giesela
    Flores, Jose
    Carnero Contentti, Edgar
    Adrian Lopez, Pablo
    Pablo Pettinicchi, Juan
    Caride, Alejandro
    Galleguillos, Lorna
    Barahona, Jorge
    Diaz, Violeta
    Hernandez, Marianella
    Alonso, Ricardo
    Cristiano, Edgardo
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (04) : 305 - 309
  • [23] Real-world experience of ocrelizumab in multiple sclerosis patients in latin america
    Rojas, J.
    Patrucco, L.
    Fruns, M.
    Flores-Rivera, J.
    Carnero Contentti, E.
    Galleguillos, L.
    Alonso, R.
    Cristiano, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 548 - 548
  • [24] Real-world experience of ocrelizumab initiation in a diverse multiple sclerosis population
    Coban, Hamza
    Germaine, Sarah
    Dimaandal, Ian
    Haberli, Nicholas
    Padam, Charanpreet
    Creed, Marina A.
    Imitola, Jaime
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 53
  • [25] Acapella: hypogammaglobulinemia and jcv status in ocrelizumab-treated patients, year two data
    Geils, H.
    Stribling, I.
    Katz, J.
    Lathi, E.
    Douglas, E.
    Bouley, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 256 - 256
  • [26] Ocrelizumab use in multiple sclerosis: a real-world experience in a changing therapeutic scenario
    Lorefice, Lorena
    Mellino, Paolo
    Frau, Jessica
    Coghe, Giancarlo
    Fenu, Giuseppe
    Cocco, Eleonora
    [J]. NEUROLOGICAL SCIENCES, 2024, 45 (08) : 3951 - 3959
  • [27] Rituximab - Ocrelizumab comparison in real-world practice
    Casanova, I.
    Lopez de Silanes, C.
    Lopez, P.
    Gomez, L.
    Abellan, S.
    Ferrando, M.
    Alvarez, R.
    Arroyo, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 714 - 714
  • [28] Adherence and persistence to ocrelizumab in a real-world cohort
    Rodriguez Regal, Ana
    Lopez Real, Ana Maria
    Alvarez Rodriguez, Elena
    Garcia-Estevez, Daniel Apolinar
    Rodriguez Rodriguez, Maria
    Pato, Antonio
    Costa, Eva
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1014 - 1014
  • [29] The real-world effectiveness of ocrelizumab for treating patients with MS: 1-year data from the MuSicalE study
    Trojano, M.
    Van Pesch, V.
    Al Roughani, R.
    Rovira, A.
    Cutter, G.
    Dzhenkova, D.
    Hagenbuch, N.
    Kantaria, R.
    Craveiro, L.
    Hobart, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 635 - 635
  • [30] ACAPELLA: hypogammaglobulinemia and JCV status in ocrelizumab-treated patients, year four data
    Douglas, E.
    Jungquist, R. -M.
    Bouley, A.
    Katz, J.
    Lathi, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 645 - 645
12345